Delivery Order SPE2DR25D3109-SPE2DR26FT2JC
- Not listed
- The Defense Logistics Agency awarded a $1,559.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a brand-name diabetes medication. The award was issued on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-set-aside, competitively awarded contract. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.95 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,308.24 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,162.96 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen (0.5 mL), a diabetes medication. This firm fixed-price delivery order was competitively awarded without any set-aside designation and is scheduled for completion by December 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication. This is a firm fixed price, non-competitive delivery order under an Indefinite Delivery Contract (IDC) with a completion date of September 18, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen 0.5 mL, a diabetes medication, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract employs firm fixed-price pricing under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee with performance occurring at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $4,410.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The award was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2JCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,308.24 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This non-set-aside, competitively awarded contract was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and carries firm fixed price terms. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's contract awards with the DLA demonstrate consistent capability in meeting federal procurement requirements for critical pharmaceutical support across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/10/25 |